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Abstract
Objective—This study examined the temporal relation between therapeutic alliance and outcome 
in two treatments for bulimia nervosa (BN).
Method—Eighty adults with BN symptoms were randomized to 21 sessions of integrative 
cognitive-affective therapy (ICAT) or enhanced cognitive-behavioral therapy (CBT-E). Bulimic 
symptoms (i.e., frequency of binge eating and purging) were assessed at each session and post-
treatment. Therapeutic alliance (Working Alliance Inventory) was assessed at sessions 2, 8, 14, 
and post-treatment. Repeated-measures analyses using linear mixed models with random 
intercepts were conducted to determine differences in alliance growth by treatment and patient 
characteristics. Mixed-effects models examined the relation between alliance and symptom 
improvement.
Results—Overall, patients in both treatments reported strong therapeutic alliances. Regardless of 
treatment, greater therapeutic alliance between (but not within) subjects predicted greater 
reductions in bulimic behavior; reductions in bulimic behavior also predicted improved alliance. 
Patients with higher depression, anxiety, or emotion dysregulation had a stronger therapeutic 
alliance in CBT-E than ICAT, while those with more intimacy problems had greater improvement 
in therapeutic alliance in ICAT compared to CBT-E.
Conclusions—Therapeutic alliance has a unique impact on outcome, independent of the impact 
of symptom improvement on alliance. Within- and between-subject effects revealed that changes 
in alliance over time did not predict symptom improvement, but rather that individuals who had a 
stronger alliance overall had better bulimic symptom outcomes. These findings indicate that 
therapeutic alliance is an important predictor of outcome in the treatment of BN.
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Therapeutic alliance is a frequently studied common factor in psychotherapy that 
consistently predicts patient improvement across clinical problems and psychotherapies 
(Castonguay, Constantino, & Holtforth, 2006), with an effect size of .28 in a recent meta-
analysis (Horvath, Del Re, Flückiger, & Symonds, 2011). Most definitions of therapeutic 
alliance converge on several aspects of this construct, including the affective bond between 
the patient and therapist, as well as their agreement on therapeutic tasks and goals (Bordin, 
1979).
However, untangling the alliance-outcome relation is complex because there are several 
potential contributors—patients, therapists, and their interaction (i.e., match), and 
determining temporal precedence is complex. While therapeutic alliance may predict 
symptomatic outcome, symptom change may also predict alliance (DeRubeis, Brotman, & 
Gibbons, 2005). Recent research suggests that therapist variability in alliance is more 
important in predicting outcome than patient variability (Baldwin, Wampold, & Imel, 2007; 
Del Re, Flückiger, Horvath, Symonds, & Wampold, 2012; Zuroff, Kelly, Leybman, Blatt, & 
Wampold, 2010). In addition, research suggests that alliance temporally precedes symptom 
improvement (Falkenström, Granström, & Holmqvist, 2014; Zilcha-Mano, Dinger, 
McCarthy, & Barber, 2013) and that prior symptom reduction can also precede alliance 
improvement (Falkenström et al., 2014).
Research has examined the alliance-outcome relation across a variety of psychiatric 
diagnoses but infrequently focused on this relationship in bulimia nervosa (BN). Therapeutic 
alliance may be particularly important in the treatment of this disorder given that 
interpersonal problems in BN are associated with symptom maintenance (Arcelus, Haslam, 
Farrow, & Meyer, 2013). Various studies suggest that alliance predicts improvements in 
binge eating (Treasure et al., 1999) and purging (Constantino, Arnow, Blasey, & Agras, 
2005; Treasure et al., 1999) across multiple therapies, but other studies find less clear 
associations (Loeb et al., 2005; Wilson et al., 1999). Several methodological and statistical 
differences may contribute to discrepant findings, including different perspectives on 
alliance (i.e., self-rated versus observer-coded); measurement (early versus mid-treatment, 
single versus repeated measures); and analysis (e.g., controlling for baseline values versus 
change scores). Given that improved symptoms in BN can lead to improved alliance 
(Wilson et al., 1999), temporal analysis that controls for prior symptom improvement is 
critical. In addition, it is necessary to account for the nested structure of treatment data (i.e., 
time nested within individuals, who are nested within therapists) to accurately examine the 
impact of alliance on outcome in the context of time, individual differences, and therapist 
effects.
Thus, this study examined the temporal relation between alliance and outcome in two BN 
treatments—integrative cognitive affective therapy (ICAT) or enhanced cognitive 
behavioral therapy (CBT-E). Both treatments are similar in their emphasis on establishing 
and maintaining a strong therapeutic alliance for treatment engagement. The main aim was 
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to examine the bidirectional relation between alliance and bulimic symptoms. Secondary 
aims were to a) examine differences in alliance over time between treatments and b) identify 




Additional details of this two-site randomized clinical trial design and treatments are 
provided in the main outcome report (Wonderlich et al., 2014). Eighty adults with DSM-5 
BN (APA, 2013) and partial BN (i.e., same criteria as DSM-5 with subjective rather than 
objective binge eating episodes) were randomized to ICAT or CBT-E. Briefly, ICAT is a 
new treatment based on the idea that emotional states serve as proximal antecedents of BN 
behavior and that BN behavior regulates emotional states. Interventions focus on identifying 
cues for binge eating and managing binge urges, normalizing eating patterns with meal 
planning, and modifying behavioral reactions to cues which elicit negative emotion 
(Wonderlich et al., 2014). In contrast, CBT-E is a recently updated but established treatment 
that employs psychoeducation, self-monitoring, and behavioral exposure to normalize eating 
patterns and modify cognitive biases, particularly over-evaluation of shape and weight 
(Fairburn, 2008). Four psychologists (two per site) delivered both treatments in 21 50-min 
sessions over 19 weeks.
Participants on a stable dose of antidepressant medication for at least 6 weeks could be 
included. Exclusion criteria included pregnancy or lactation, body mass index (BMI) < 18, 
lifetime bipolar or psychotic disorder, current substance use disorder, medical or psychiatric 
instability, and current psychotherapy. Written informed consent was obtained from all 
participants. The institutional review boards at each site approved this study.
Measures
At baseline, trained interviewers determined eating disorder diagnosis (Eating Disorder 
Examination: EDE) (Fairburn, 2008) and comorbid psychiatric diagnoses (Structured 
Clinical Interview for DSM-IV Axis I Disorders – Patient Version: SCID-I/P; First et al., 
2002). The EDE also provided a measure of initial eating disorder symptoms (EDE global 
score). Additional measures at baseline assessed depressive symptoms (Beck Depression 
Inventory: BDI; Beck et al., 1961), anxiety symptoms (Spielberger Trait Anxiety Inventory: 
STAI (Spielberger et al. 1970), emotion dysregulation (Difficulties in Emotion Regulation 
Scale: DERS; Gratz & Roemer, 2004), and personality pathology (Dimensional Assessment 
of Personality Pathology, Basic Questionnaire: DAPP-BQ; Livesley & Jackson, 2009). 
Patients reported on therapeutic alliance at sessions 2, 8, 14, and post-treatment, which 
occurred the week after the last session (Working Alliance Inventory: WAI; Horvath & 
Greenberg, 1986). Bulimic symptoms (i.e., frequency of binge eating episodes and purging 
episodes) were assessed through weekly written patient recalls at each session, post-
treatment, and treatment follow-up (32 weeks).
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Repeated-measures analyses using linear mixed models with an autoregressive (order 1) 
covariance structure and random intercepts were used to examine the bidirectional relation 
between alliance and bulimic symptoms with SPSS Version 22. Two separate models tested 
whether therapeutic alliance (at sessions 2, 8, 14, and post-treatment) predicted subsequent 
improvement in bulimic symptoms (at sessions 3–7, 9–13, 15–21, and treatment follow-up, 
using the average number of bulimic behaviors per week over the specified time period), 
controlling for bulimic behaviors episodes in the preceding week (at sessions 2, 8, 14, and 
post-treatment; see supplementary material for visual diagram). Models included a random 
intercept, random effects for time (centered at mid-treatment) and therapist, and fixed effects 
for treatment and therapeutic alliance. Therefore, the main effect for therapeutic alliance and 
its interaction with time were entered as both a within-subjects (alliancewithin-subjects, person-
mean centered around each person’s individual trend-line as a time-varying covariate) and 
between-subjects variable (alliancebetween-subjects, grand-mean centered person means—the 
intercept of each person’s individual trend-line—as a time invariant covariate; Curran & 
Bauer, 2011).
Another mixed-effects model examined whether improvements in bulimic behavior earlier 
in treatment (measured as the difference between weekly number of binge eating and 
purging episodes at sessions 1, 8, and 14 and the average number of binge eating and 
purging episodes per week between sessions 2–7, 9–13, and 15–21) predicted subsequent 
improvement in alliance (measured at sessions 8, 14, and post-treatment). This model 
included a random intercept, random effects for time (centered at mid-treatment) and 
therapist, and fixed effects for treatment, average number of bulimic behaviors per week 
(entered separately as within-subjects centered covariates), and alliance at time points 
preceding the dependent variable.
Mixed-effects models were also used to examine differences in alliance over time between 
treatments (a) and to identify clinical characteristics that predicted alliance or moderated the 
effect of treatment on alliance (b). Baseline predictors of alliance included age, sex, BMI, 
eating disorder severity (EDE Global), anxiety symptoms (STAI), depressive symptoms 
(BDI), emotion dysregulation (DERS), lifetime substance abuse (SCID-I/P), and personality 
pathology (DAPP subscales, examined as a set). These predictors were examined in separate 
linear mixed models, including main effects and all two- and three-way interactions with 
treatment and time, with random intercepts and random effects for time and therapist.
Results
Participants were predominantly Caucasian (87.5%) females (n = 72, 90%) with a mean age 
of 27.3 (SD = 9.6), mean BMI of 23.9 (SD = 5.5), and mean EDE global score of 3.3 (SD = 
1.1). The majority (72.5%, n = 58) met full threshold DSM-5 criteria for BN. There were no 
significant differences by treatment on any demographic or clinical characteristics at 
baseline.
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What is the nature of the relation between alliance and bulimic symptoms?
Does therapeutic alliance predict reductions in bulimic symptoms?—After 
controlling for bulimic symptoms at a previous time point, several predictors of bulimic 
symptoms at a subsequent time point emerged (see Table 1). There was a significant main 
effect for between-subjects therapeutic alliance (B = −0.100, SE = 0.029, 95% CI [−0.158, 
−0.042], p = .001), such that individuals with a stronger therapeutic alliance reported greater 
reductions in bulimic symptoms. There was no effect between time and between-subjects 
therapeutic alliance (p = .98), indicating that the relation between the alliance and bulimic 
symptom reduction remained constant over time. Time (p = .97), treatment (p = .30), 
therapist (p = .11), and within-subjects therapeutic alliance (p = .51) were not associated 
with reductions in bulimic symptoms.
Does symptom improvement predict improved alliance?—In the reverse model 
with alliance as the outcome, reductions in bulimic symptoms predicted improved alliance 
(B = −0.346, SE = 0.152, 95% CI [−0.646, −0.046], p = .024), after controlling for prior 
alliance (see Table 2). There were no effects of time, treatment, or therapist on alliance (ps 
> .06).
Does alliance across time differ between treatments?
Early therapeutic alliance (session 2) was relatively high in both ICAT (M = 222.53, SD = 
19.84) and CBT-E (M = 220.08, SD = 19.27) (possible range: [36,252]). In the model that 
included treatment, time, and their interaction as predictors, alliance remained stable across 
time (B = 0.305, SE = 0.222, 95% CI [−0.133, 0.743], p = .17), and alliance strength did not 
differ overall (B = −3.129, SE = 2.932, 95% CI [−8.902, 2.644], p = .29) or across time 
between treatments (B = −0.400, SE = 0.319, 95% CI [−1.028, 0.229], p = .21).
What factors predict alliance or moderate the effect of treatment on alliance?
There were main effects for depression (B = −0.752, SE = 0.174, 95% CI [−1.096, −0.409], 
p < .0001), anxiety (B = −0.718, SE = 0.147, 95% CI [−1.008, −0.428], p < .0001), and 
emotion dysregulation (B = −0.196, SE = 0.074, 95% CI [−0.341, −0.051], p = .008), 
indicating that therapeutic alliance was greater overall for patients with less depression, 
anxiety, and emotion dysregulation. There were also corresponding two-way interactions 
with treatment, indicating that the relationship between treatment type and alliance varied by 
level of depression (B = 0.921, SE = 0.251, 95% CI [0.426, 1.416], p = .0003), anxiety (B = 
0.638, SE = 0.234, 95% CI [0.178, 1.098], p = .007), and emotion dysregulation (B = 0.261, 
SE = 0.117, 95% CI [0.030, 0.492], p = .027). Specifically, individuals in CBT-E had similar 
levels of therapeutic alliance across levels of symptomatology (i.e., depression, anxiety, 
emotion dysregulation), whereas individuals in ICAT with low levels of symptomatology 
reported a stronger therapeutic alliance than those with high levels of symptomology (see 
Figures 1–3). Finally, there was a three-way interaction between treatment, time, and DAPP-
BQ Intimacy Problems, which revealed that differences in intimacy problems moderated the 
impact of treatment type on therapeutic alliance over the course of treatment (B = 0.076, SE 
= 0.031, 95% CI [0.013, 0.138], p = .019). In CBT-E, individuals with high intimacy 
problems had growth in alliance over time while those with low intimacy problems had 
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deteriorations in alliance; in ICAT, individuals with high intimacy problems had lower 
initial alliance but greater growth in alliance, while those with low intimacy problems had 
high and stable alliance across time (see Figure 4). The main effects of age, sex, BMI, eating 
disorder severity, substance abuse history, and affective lability and their interactions with 
treatment (ps > .07) were not significant predictors of alliance; the effect of therapist on 
alliance level was also non-significant across models (ps > .07).
Discussion
This study found that patients with BN reported strong therapeutic alliances that were stable 
across time in two treatments. A stronger alliance predicted greater improvements in bulimic 
behavior. However, between-patient alliance (i.e., individuals’ mean level of alliance across 
time) was what contributed to the alliance-outcome relation, rather than the within-
individual alliance (i.e., individuals’ change in alliance over time). Thus, individuals with 
stronger overall alliances had greater reductions in bulimic behavior. Additionally, greater 
reductions in bulimic behavior predicted improved therapeutic alliance. The bidirectional 
nature of the alliance-outcome relation is consistent with prior research in BN (Wilson et al., 
1999).
Although therapists did not contribute to overall therapeutic alliance strength, certain patient 
characteristics were associated with a stronger alliance across time between treatments. 
Higher levels of depression, anxiety, and emotion dysregulation were associated with lower 
overall alliance. Further, each variable’s interaction with treatment indicated that patients 
with higher symptomatology reported stronger overall therapeutic alliances in CBT-E, 
whereas those with lower symptomatology reported stronger overall therapeutic alliances in 
ICAT. Patients with high intimacy problems also had greater growth in alliance over time in 
ICAT than CBT-E, whereas those with low intimacy problems had deteriorating alliance in 
CBT-E (but stable alliance in ICAT). Greater alliance in CBT-E for individuals with high 
emotionality could be due to CBT-E’s relatively more prescriptive, structured approach 
focused on accomplishing concrete tasks. This approach may have been experienced as 
more predictable and attainable for patients with this type of psychopathology, whereas the 
emotion-focused aspects of ICAT may have been more challenging. In contrast, individuals 
with low emotionality and intimacy problems may have enjoyed ICAT’s focus on emotional 
states within the interpersonal context, which was approachable for these patients. For those 
with high intimacy problems in ICAT, lower initial alliance but greater growth in alliance 
over time may reflect greater initial difficulty with ICAT’s emotional-interpersonal focus 
but easier engagement in these tasks over time.
Some patient characteristics were associated with greater alliance in CBT (high 
symptomatology); others were associated with greater alliance in ICAT (low 
symptomatology and intimacy problems). However, these results do not suggest that one 
therapeutic approach is superior to the other for particular individuals, and future analyses 
are needed to examine moderators of treatment outcome. These results are somewhat 
surprising given that only one other study of BN has found differences in alliance by patient 
characteristics (Constantino & Smith-Hansen, 2008); most others have found equivalent 
alliance across treatments (Loeb et al., 2005; Treasure et al., 1999; Wilson et al., 1999). 
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While this analysis provides some insight into patient and treatment characteristics that 
contribute to stronger patient-therapist alliances, it was limited in its ability to examine the 
impact of therapist characteristics or their interaction with patient characteristics on alliance. 
Although there was a significant therapist effect in this study, our small therapist sample 
limits the generalizability of this finding.
This study contributes to our understanding of the causal direction of the alliance-outcome 
relation. Strengths include the use of multilevel statistical models that examined the 
bidirectional, longitudinal relation between alliance and symptom improvement for adults 
with BN and partial BN across two treatments, thereby increasing the generalizability of the 
results. Additionally, these models accounted for between- and within-subject effects, as 
well as therapist effects. Despite unique methodology, this study was limited by its relatively 
modest sample size. Given only 80 patients and four therapists, the various possible patient-
therapist combinations with respect to gender, race/ethnicity, and other personal 
characteristics are restricted, hindering a more thorough examination of alliance and 
therapist effects. Furthermore, the sample size restricted an examination of within- and 
between-therapist effects, which would have clarified how patient outcomes would differ 
based on therapists’ tendency to form stronger or weaker alliances with their patients, on 
average. The clinical implications of this analysis are critical, given that therapist actions or 
characteristics may be driving the alliance-outcome effect. Although alliance was assessed 
four times (about six sessions apart), more frequent assessment would have enabled a more 
detailed study of the bidirectional alliance-outcome relation. In addition, this study relied on 
patient self-report, without evaluating therapist or observer perspectives on therapeutic 
alliance. Self-reported alliance was high with minimal within-patient variability, limiting its 
potential as a robust predictor of outcome. Finally, this recruited sample may be somewhat 
unique from “usual” patients who present for non-randomized clinical care with respect to 
motivation and willingness to engage in a manualized intervention.
Therapeutic alliance appears to be an important predictor of reduced bulimic behavior, 
which in turn preceded improvements in alliance. The alliance-outcome relation was due to 
between- rather than within-patient therapeutic alliance, but the small sample of therapists 
limited this study’s ability to address the importance of patient versus therapist contributions 
to the alliance. Nevertheless, this study offers preliminary information about patient 
characteristics that may indicate the type of treatment in which a patient will feel most 
aligned with his/her therapist. Future research should examine how the therapist-patient 
interaction contributes to the alliance-outcome relation, as well as directly examine how 
particular patient characteristics may moderate the relation between treatment and outcome.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This research was supported by grants R01DK61912, R01DK61973, and P30DK60456 from the National Institute 
of Diabetes and Digestive and Kidney Diseases, grants R34MH077571 and T32MH082761 from the National 
Accurso et al. Page 7













Institute of Mental Health, and the Neuropsychiatric Research Institute. [Clinical Trials.gov Identifier: 
NCT00773617.]
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fifth edition. 
Arlington, VA: American Psychiatric Association; 2013. 
Arcelus J, Haslam M, Farrow C, Meyer C. The role of interpersonal functioning in the maintenance of 
eating psychopathology: A systematic review and testable model. Clinical Psychology Review. 
2013; 33:156–167. [PubMed: 23195616] 
Baldwin SA, Wampold BE, Imel ZE. Untangling the alliance-outcome correlation: Exploring the 
relative importance of therapist and patient variability in the alliance. Journal of Consulting and 
Clinical Psychology. 2007; 75:842–852. [PubMed: 18085902] 
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. 
Archives of General Psychiatry. 1961; 4:561–571. [PubMed: 13688369] 
Bordin ES. The generalizability of the psychodynamic concept of the working alliance. Psychotherapy: 
Theory, Research, and Practice. 1979; 16:252–260.
Castonguay LG, Constantino MJ, Holtforth MG. The working alliance: Where are we and where 
should we go? Psychotherapy: Theory, Research, Practice, Training. 2006; 43:271–279.
Constantino MJ, Arnow BA, Blasey C, Agras WS. The association between patient characteristics and 
the therapeutic alliance in cognitive-behavioral and interpersonal therapy for bulimia nervosa. 
Journal of Consulting and Clinical Psychology. 2005; 73:203–211. [PubMed: 15796627] 
Constantino M, Smith-Hansen L. Patient interpersonal factors and the therapeutic alliance in two 
treatments for bulimia nervosa. Psychotherapy Research. 2008; 18:683–698. [PubMed: 18815953] 
Curran PJ, Bauer DJ. The disaggregation of within-person and between-person effects in longitudinal 
models of change. Annual Review of Psychology. 2011; 62:583–619.
Del Re AC, Flückiger C, Horvath AO, Symonds D, Wampold BE. Therapist effects in the therapeutic 
alliance-outcome relationship: A restricted-maximum likelihood meta-analysis. Clinical 
Psychology Review. 2012; 32:642–649. [PubMed: 22922705] 
DeRubeis RJ, Brotman MA, Gibbons CJ. A conceptual and methodological analysis of the 
nonspecifics argument. Clinical Psychology: Science and Practice. 2005; 12:174–183.
Fairburn, CG. Cognitive Behavior Therapy and Eating Disorders. New York: Guilford; 2008. 
Falkenström F, Granström F, Holmqvist R. Working alliance predicts psychotherapy outcome even 
while controlling for prior symptom improvement. Psychotherapy Research. 2014; 24:146–159. 
[PubMed: 24188079] 
First, MB.; Spitzer, RL.; Gibbon, M.; Williams, JBW. Structured clinical interview for DSM-IV Axis I 
disorders, patient version (SCID-I/P). New York: New York State Psychiatric Institute, Biometrics 
Research Department; 2002. 
Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: 
Development, factor structure, and initial validation of the Difficulties in Emotion Regulation 
Scale. Journal of Psychopathology and Behavior Assessment. 2004; 26:41–54.
Horvath, AO.; Greenberg, LS. Development of the Working Alliance Inventory. In: Greenberg, LS.; 
Pinsoff, WM., editors. The psychotherapeutic process: A research handbook. New York: Guilford; 
1986. p. 529-556.
Horvath AO, Del Re AC, Flückiger C, Symonds D. Alliance in individual psychotherapy. 
Psychotherapy. 2011; 48:9–16. [PubMed: 21401269] 
Livesley, WJ.; Jackson, DN. Dimensional Assessment of Personality Pathology—Basic Questionnaire: 
Technical manual. Port Huron, MI: Sigma Assessment Systems; 2009. 
Loeb KL, Wilson GT, Labouvie E, Pratt EM, Hayaki J, Walsh BT, Fairburn CG. Therapeutic alliance 
and treatment adherence in two interventions for bulimia nervosa: a study of process and outcome. 
Journal of Consulting and Clinical Psychology. 2005; 73:1097–1107. [PubMed: 16392983] 
Spielberger, CD.; Gorsuch, RL.; Lushene, RE. Manual for the State-Trait Anxiety Inventory. Palo 
Alto, CA: Consulting Psychologists Press; 1970. 
Accurso et al. Page 8













Treasure JL, Katzman M, Schmidt U, Troop N, Todd G, de Silva P. Engagement and outcome in the 
treatment of bulimia nervosa: First phase of a sequential design comparing motivation 
enhancement therapy and cognitive behavioural therapy. Behaviour Research and Therapy. 1999; 
37:405–418. [PubMed: 10228313] 
Wilson GT, Loeb KL, Walsh BT, Labouvie E, Petkova E, Liu X, Waternaux C. Psychological versus 
pharmacological treatments of bulimia nervosa: Predictors and processes of change. Journal of 
Consulting and Clinical Psychology. 1999; 67:451–459. [PubMed: 10450615] 
Wonderlich SA, Peterson CB, Crosby RD, Smith TL, Klein MH, Mitchell JE, Crow SJ. A randomized 
controlled comparison of integrative cognitive-affective therapy (ICAT) and enhanced cognitive-
behavioral therapy (CBT-E) for bulimia nervosa. Psychological Medicine. 2014; 44:543–553. 
[PubMed: 23701891] 
Zilcha-Mano S, Dinger U, McCarthy KS, Barber JP. Does alliance predict symptoms throughout 
treatment, or is it the other way around? Journal of Consulting and Clinical Psychology. 2013 
Advance online publication. 
Zuroff DC, Kelly AC, Leybman MJ, Blatt SJ, Wampold BE. Between-therapist and within-therapist 
differences in the quality of the therapeutic relationship: effects on maladjustment and self-critical 
perfectionism. Journal of Clinical Psychology. 2010; 66:681–697. [PubMed: 20527050] 
Accurso et al. Page 9














This study highlights the importance of a strong therapeutic alliance for good treatment 
outcome in bulimia nervosa. Individuals’ improvements in alliance over the course of 
treatment did not specifically predict subsequent symptom improvement, but individuals 
with stronger overall alliances had superior symptom reductions overall.
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Level of alliance by treatment and level of depressive symptoms (high symptoms = 1SD 
above the mean, low symptoms = 1SD below the mean).
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Level of alliance by treatment and level of anxiety symptoms (high symptoms = 1SD above 
the mean, low symptoms = 1SD below the mean).
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Level of alliance by treatment and level of emotion dysregulation (high dysregulation = 1SD 
above the mean, low dysregulation = 1SD below the mean).
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Growth in alliance over time by treatment and level of intimacy problems (high problems = 
1SD above the mean, low problems = 1SD below the mean).
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Table 1
The impact of therapeutic alliance on reductions in bulimic behavior.
Predictors Estimate SE 95% CI p
Time 0.036 0.814 [−1.596, 1.667] .965
Treatment −1.266 1.222 [−3.678, 1.146] .302
Therapist .112
  therapist 1 (v. 4) 3.455 1.630 [0.237, 6.672] .036
  therapist 2 (v. 4) 2.521 2.026 [−1.476, 6.519] .215
  therapist 3 (v. 4) 0.395 1.630 [−2.823, 3.613] .809
alliancewithin-subjects −0.044 0.066 [−0.175, 0.087] .507
alliancewithin-subjects × time 0.005 0.009 [−0.013, 0.023] .602
alliancebetween-subjects −0.100 0.029 [−0.158, −0.042] .001
alliancebetween-subjects × time <0.001 0.004 [−0.007, 0.007] .983
prior bulimic behavior 0.365 0.143 [0.083, 0.646] <.001
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Table 2
The impact of bulimic symptom reduction on improvements in therapeutic alliance.
Predictors Estimate SE 95% CI P
Time 0.327 0.173 [−0.017, 0.671] .062
therapist .161
  therapist 1 (v. 4) 5.784 2.649 [0.543, 11.026] .031
  therapist 2 (v. 4) 2.093 3.268 [−4.381, 8.567] .523
  therapist 3 (v. 4) 2.942 2.842 [−2.681, 8.565] .303
treatment 2.121 1.918 [−1.674, 5.917] .271
bulimic behavior −0.346 0.152 [−0.646, −0.046] .024
prior alliance 0.822 0.044 [0.736, 0.908] <.0001
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